[1]
Walia, S. and Varma, P. 2013. Bevacizumab (Avastin) for Ocular Disorders. International Journal of Pharmacological Research. 3, 4 (Dec. 2013), 59–68. DOI:https://doi.org/10.7439/ijpr.v3i4.55.